Aravive, Inc. financial data

Industry
Pharmaceutical Preparations
Location
River Oaks Tower, 3730 Kirby Drive, Suite 1200, Houston, TX
State of incorporation
TX
Fiscal year end
December 31
Former names
Versartis, Inc. (to 10/5/2018)
Latest financial report
10-Q - Q3 2023 - Nov 9, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 194 % -27.2%
Debt-to-equity -413 % -561%
Return On Equity 346 %
Return On Assets -111 % -10.3%
Operating Margin -847 % -13.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 73.6M shares +23%
Common Stock, Shares, Outstanding 73.6M shares +141%
Entity Public Float 19.1M USD -78.6%
Common Stock, Value, Issued 7K USD +133%
Weighted Average Number of Shares Outstanding, Basic 75.7M shares +148%
Weighted Average Number of Shares Outstanding, Diluted 76.1M shares +149%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 7M USD -19.1%
General and Administrative Expense 12.9M USD +6.5%
Operating Income (Loss) -59.3M USD +8.28%
Nonoperating Income (Expense) 19.4M USD +334%
Net Income (Loss) Attributable to Parent -39.8M USD +33.8%
Earnings Per Share, Basic -0.5 USD/shares +78.9%
Earnings Per Share, Diluted 0.28 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.54M USD -69.4%
Accounts Receivable, after Allowance for Credit Loss, Current 6M USD
Assets, Current 9.56M USD -74.7%
Property, Plant and Equipment, Net 167K USD -43.4%
Operating Lease, Right-of-Use Asset 907K USD -45%
Other Assets, Noncurrent 5K USD +25%
Assets 13M USD -69.1%
Accounts Payable, Current 5.42M USD -38.5%
Employee-related Liabilities, Current 274K USD -83.9%
Accrued Liabilities, Current 2.23M USD -69.2%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 9.78M USD -58.8%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 306K USD -87.4%
Liabilities 11.3M USD -58.2%
Retained Earnings (Accumulated Deficit) -627M USD -6.79%
Stockholders' Equity Attributable to Parent 1.7M USD -88.7%
Liabilities and Equity 13M USD -69.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17.8M USD -37.7%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Common Stock, Shares Authorized 250M shares +150%
Common Stock, Shares, Issued 73.6M shares +141%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -17.8M USD -377%
Deferred Tax Assets, Valuation Allowance 18.2M USD -21.5%
Deferred Tax Assets, Gross 18.5M USD -21.8%
Operating Lease, Liability 2.43M USD -47.8%
Lessee, Operating Lease, Liability, to be Paid 3.54M USD -46%
Property, Plant and Equipment, Gross 4.11M USD +0.27%
Operating Lease, Liability, Current 2.12M USD -4.46%
Lessee, Operating Lease, Liability, to be Paid, Year Two 116K USD -95.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.62M USD -13.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.11M USD -41.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 30K USD -74.1%
Deferred Tax Assets, Operating Loss Carryforwards 504K USD -97.2%
Unrecognized Tax Benefits 165K USD +0.61%
Lessee, Operating Lease, Liability, to be Paid, Year Four 30K USD -74.1%
Operating Lease, Payments 800K USD +14.3%
Depreciation, Depletion and Amortization 215K USD -3.15%
Share-based Payment Arrangement, Expense 2.32M USD -9.81%